The clinical efficacy of topiramate in the treatment of epilepsy

Reviews in Contemporary Pharmacotherapy

Volumn 10, Issue 3, 1999, Pages 163-184

  Ben Menachem, Elinor ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; LAMOTRIGINE; TIAGABINE; TOPIRAMATE; VIGABATRIN; ZONISAMIDE;

ADULT; ANTICONVULSANT ACTIVITY; CHILD; CLINICAL TRIAL; DRUG SCREENING; GRAND MAL SEIZURE; HUMAN; INFANT; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; META ANALYSIS; REVIEW; SEIZURE; TONIC CLONIC SEIZURE; WEST SYNDROME;

EID: 0032700052     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Abou-Khalil, YOL Topiramate Study Group. Topiramate therapy in the long-term management of epilepsy. Epilepsia 1997; 38 (Suppl 3): 60.
2. Aranguiz C, McJilton J, Vega M, Ramsay RE. Safety and effectiveness of three oral doses of topiramate in the treatment of patients with refractory partial epilepsy. Epilepsia 1991; 32 (Suppl 3): 11.
3. Bauer G, Crawford P, Canger R, YOL-E Study Group. Open-label, long-term topiramate therapy for epilepsy. Epilepsia 1997; 38 (Suppl 3): 58-59.
4. Ben-Menachem E. Long-term follow-up of patients treated with topiramate for partial seizures. Epilepsia 1995; 36 (Suppl 3): 152.
5. Ben-Menachem E. Expanding antiepileptic drug options: clinical efficacy of new therapeutic agents. Epilepsia 1996; 37 (Suppl 2): S4-S7.
6. Biton V, Chadwick D, Montouris GD, Shu-Chen W. Topiramate as long-term therapy in patients with generalized tonic-clonic seizures without focal onset. Neurology 1998; 50: A311-A312.
7. Biton V, Montouris GD, Ritter F et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology 1999; 52: 1330-1337.
8. Brodie MJ, Biton V, Montouris GD, Shu-Chen W. Topiramate therapy in patients with generalized tonic-clonic seizures without focal onset: long-term outcome. Epilepsia 1998; 39 (Suppl 2): 2.
9. Brown SD, Wolf HH, Swinyard EA, Twyman RE, White HS. The novel anticonvulsant topiramate enhances GABA-mediated chloride flux. Epilepsia 1993; 34 (Suppl 2): 122.
10. Bruni J. Efficacy of topiramate. Can J Neurol Sci 1998; 25: S6-S7.
11. Canger R, Guidolin L, DiFazio M. Topiramate in the treatment of partial refractory epilepsy: an open-label study with long-term follow-up. Epilepsia 1996; 37 (Suppl 4): 61.
12. Canger R, Avanzini G, Tartara A et al. Long-term efficacy and tolerability of topiramate add-on therapy: interim analysis after four years of treatment. Epilepsia 1997; 38 (Suppl 3): 59.
13. Chadwick DW. An overview of the efficacy and tolerability of new antiepileptic drugs. Epilepsia 1997; 38 (Suppl 1): S59-S62.
14. Chadwick D, Leiderman DB, Sauermann W, Alexander J, Garofalo E. Gabapentin in generalized seizures. Epilepsy Res 1996; 25: 191-197.
15. Chugani HT. Infantile spasms. Curr Opin Neurol 1995; 8: 139-144.
16. Clark PO, Glauser TA, Strawsburg R. Pilot study of topiramate in children with infantile spasms. Epilepsia 1997; 38 (Suppl 8): 97.
17. Coulter DA, Sombati S, DeLorenzo RJ. Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons. Epilepsia 1993; 34 (Suppl 2): 123.
18. Cowell PG, Coles HJ, Crawford PM. Topiramate as adjunctive therapy in patients with refractory epilepsy: a report of a long-term, open-label study. Epilepsia 1995; 36 (Suppl 3): 152.
19. Crawford P. An audit of topiramate use in a general neurology clinic. Seizure 1998; 7: 207-211.
20. Datta PK, Crawford PM. Audit of topiramate use in a general neurology clinic. Epilepsia 1998; 39 (Suppl 2): 3.
21. Durisotti C, Garofalo P, DiFazio M. Topiramate as add-on, open therapy in drug-resistant epilepsies: one year of follow-up. Epilepsia 1996; 37 (Suppl 4): 89.
22. Edwards K, Norton J, Potter D. Assessment of efficacy and tolerability of topiramate in slow versus rapid titration. Epilepsia 1997; 38 (Suppl 3): 59.
23. Elterman R, Glauser TA, Ritter FJ et al. A double-blind trial of topiramate in partial seizures in children. Epilepsia 1997a; 38 (Suppl 3): 131.
24. Elterman R, Glauser TA, Ritter FJ, Reife R, Wu S-C, Topiramate YP Study Team. Topiramate as adjunctive therapy in pediatric patients with partial-onset seizures. Epilepsia 1997b; 38 (Suppl 8): 98.
25. Elterman RD, Glauser TA, Wyllie E et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999; 52: 1338-1344.
26. Engelskjon T, Johannessen SI, Kloster R, Nakken KO, Lossius R, Henriksen O. Long-term effect of topiramate in refractory partial epilepsy. Epilepsia 1993; 34 (Suppl 2): 123.
27. Espe-Lillo J, Ritter FJ, Frost MD, Spiegel RH, Reife RA. Safety and efficacy of topiramate in pediatric subjects. Epilepsia 1994; 35 (Suppl 8): 162.
28. Espe-Lillo J, Ritter FJ, Frost MD, Spiegel RH, Reife RA. Topiramate in childhood epilepsy: titration, adverse events, and efficacy in multiple seizure types. Epilepsia 1995; 36 (Suppl 4): 56.